Skip to main content
. 2003 Aug 18;198(4):569–580. doi: 10.1084/jem.20030590

Figure 5.

Figure 5.

Endogenous host B or T lymphocytes are not required for the treatment of established B16 tumors. C57BL/6 Rag-1−/− knockout mice bearing subcutaneous B16 tumors established for 14 d were treated with 106 cultured pmel-1 cells given in combination with rFPVhgp100 and IL-2 as described previously. Similar results were obtained in five independently completed experiments.